Primary Care-Recorded Mental Illness Decreased During COVID-19
FRIDAY, Jan. 15, 2021 -- In April 2020, there were reductions in primary care-recorded mental illness and self-harm in the United Kingdom, according to a study published online Jan. 11 in The Lancet Public Health.
Matthew J. Carr, Ph.D., from the University of Manchester in the United Kingdom, and colleagues assessed temporal trends in common mental illness, episodes of self-harm, psychotropic medication prescribing, and referrals to mental health services during COVID-19 in the United Kingdom. Data were extracted from patient records primarily from January 2019 to September 2020. A total of 14,210,507 patients from 1,697 U.K. general practices were identified.
The researchers found that compared with expected rates, in April 2020, the incidence of primary care-recorded depression, anxiety disorders, and first antidepressant prescribing had reduced by 43.0, 47.8, and 36.4 percent, respectively, in English general practices. The largest reductions in first diagnoses of depression and anxiety disorder were seen for adults of working age (18 to 44 and 45 to 64 years) and for patients registered at practices in more deprived areas. In April 2020, the incidence of self-harm was 37.6 percent lower than expected, with the greatest reduction seen for women and those aged younger than 45 years. The rate of referral to mental health services in April 2020 was less than a quarter of expected for the time of year (75.3 percent reduction).
"This research is so important because it shows the scale of the drop in the number of people seeking help, and, crucially, the treatment gaps," Carr said in a statement.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 1 to 5, 2021. This roundup...
FRIDAY, March 5, 2021 -- Countries worldwide are struggling to find enough syringes to administer COVID-19 vaccines. Experts say between 8 billion and 10 billion syringes are...
FRIDAY, March 5, 2021 -- Two cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 identified in Minnesota are described in a report published in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.